The conundrum of COVID-19 treatment targets: The close correlation with rheumatology. Response to: Ͽ Management of rheumatic diseases in the time of covid-19 pandemic: Perspectives of rheumatology pracitioners from India' by Gupta et al and Antirheumatic agents in covid-19: Is IL-6 the right target?' by Capeechi et al

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
JournalAnnals of the Rheumatic Diseases
Publication statusAccepted/In press - Jan 1 2020


  • arthritis, rheumatoid
  • immune system diseases
  • inflammation

ASJC Scopus subject areas

  • Immunology and Allergy
  • Rheumatology
  • Immunology
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this